2023 annual financial data
Sonoma Pharmaceuticals 2023 Operating margin
Sonoma Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -34.43%.
Operating income was -4,570,000 USD and net income was -5,151,000 USD.
Operating cash flow was -6,152,000 USD.
Get free Sonoma Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,272,000 USD
- Operating income
- -4,570,000 USD
- Net income
- -5,151,000 USD
- Operating cash flow
- -6,152,000 USD